The efficacy assessment of convalescent plasma therapy for COVID-19 patients: a multi-center case series
Convalescent plasma (CP) transfusion has been indicated as a promising therapy in the treatment for other emerging viral infections. However, the quality control of CP and individual variation in patients in different studies make it rather difficult to evaluate the efficacy and risk of CP therapy f...
- Autores:
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2020
- Institución:
- Universidad de Bogotá Jorge Tadeo Lozano
- Repositorio:
- Expeditio: repositorio UTadeo
- Idioma:
- eng
- OAI Identifier:
- oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/14460
- Acceso en línea:
- https://doi.org/10.1038/s41392-020-00329-x
http://hdl.handle.net/20.500.12010/14460
- Palabra clave:
- COVID-19
COVID-19 patients
Multi-center case series
Convalescent plasma therapy
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
- Rights
- License
- Abierto (Texto Completo)